Listed by the USPTO as NOBLE, MARCIA STEPHENS
Tech Center 1600 • Art Units: 1632
This examiner grants 67% of resolved cases
NOBLE, MARCIA STEPHENS is assigned to tech center 1600 and art unit 1632. The record contains 859 resolved cases, with an allowance rate of 67.2%. The median time to allowance is 1166 days. Interview lift is 39.5%, indicating that interviews have been associated with a substantial improvement in allowance outcomes.
The leading applicants are Whitehead Institute for Biomedical Research, Zoetis LLC, and Genesis Technologies Limited. The principal firms are WILSON SONSINI GOODRICH & ROSATI, Clark+Elbing LLP, and DINSMORE & SHOHL LLP. These recurring participants provide useful context for practitioners assessing similar matters. The combination of the allowance, timing, and interview measures supports early planning for examiner engagement and realistic management of prosecution duration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18884796 | ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM | Non-Final OA | Zoetis Services LLC |
| 18336001 | HUMAN PRIMARY MYELOFIBROSIS CELL STRAIN AND USE THEREOF | Final Rejection | ZHEJIANG UNIVERSITY |
| 17722312 | VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS | Non-Final OA | The Regents of the University of California |
| 18740453 | DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY | Non-Final OA | President and Fellows of Harvard College |
| 18648678 | METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10 | Non-Final OA | The Regents of the University of Colorado, a Body Corporate |
| 17204147 | Hybrid Thymus, Methods of Making, and Methods of Using to Induce Xenograft Tolerance, Restore Immunocompetence and Thymic Function | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18276164 | Engineered NKT Cells for Expansion and In Vivo Preservation and Methods of Use for the Control of Tumor Cells | Non-Final OA | Baylor College of Medicine |
| 18571533 | COMPOSITION AND PROCESS FOR AN INFILTRATION AND TRANSPORT MEDIUM FOR ADIPOSE TISSUE CELLS | Non-Final OA | UNIVERSITEIT GENT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy67.2% of resolved applications examined by Marcia Stephens Noble were allowed (859 resolved cases), compared with 38.1% across Art Unit 1632 over the last five years.
This examiner's interview lift is +39.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Marcia Stephens Noble took 1,166 days on average from filing to allowance.
Marcia Stephens Noble examines applications in Art Unit 1632 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
